Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: CRVS) | Delayed: 10.53 -0.12 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.65 | 52 Week High | $17.77 | |||
| Open | $10.58 | 52 Week Low | $9.63 | |||
| Day High | $10.65 | P/E | N/A | |||
| Day Low | $10.08 | EPS | $0.00 | |||
| Volume | 933,770 | |||||
